SG132393G - Transcutaneous application of nicotine - Google Patents

Transcutaneous application of nicotine

Info

Publication number
SG132393G
SG132393G SG132393A SG132393A SG132393G SG 132393 G SG132393 G SG 132393G SG 132393 A SG132393 A SG 132393A SG 132393 A SG132393 A SG 132393A SG 132393 G SG132393 G SG 132393G
Authority
SG
Singapore
Prior art keywords
nicotine
tobacco
variety
delivered
dose
Prior art date
Application number
SG132393A
Other languages
English (en)
Inventor
Frank T Etscorn
Original Assignee
New Mexico Tech Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8196308&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG132393(G) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by New Mexico Tech Res Found filed Critical New Mexico Tech Res Found
Priority to SG132393A priority Critical patent/SG132393G/en
Publication of SG132393G publication Critical patent/SG132393G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
SG132393A 1986-05-23 1993-12-15 Transcutaneous application of nicotine SG132393G (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG132393A SG132393G (en) 1986-05-23 1993-12-15 Transcutaneous application of nicotine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP86401095A EP0246385B1 (fr) 1986-05-23 1986-05-23 Administration de nicotine par voie transcutanée
SG132393A SG132393G (en) 1986-05-23 1993-12-15 Transcutaneous application of nicotine

Publications (1)

Publication Number Publication Date
SG132393G true SG132393G (en) 1994-03-31

Family

ID=8196308

Family Applications (1)

Application Number Title Priority Date Filing Date
SG132393A SG132393G (en) 1986-05-23 1993-12-15 Transcutaneous application of nicotine

Country Status (6)

Country Link
US (1) US4597961A (fr)
EP (2) EP0246385B1 (fr)
AT (1) ATE88366T1 (fr)
DE (1) DE3688329T2 (fr)
HK (1) HK7794A (fr)
SG (1) SG132393G (fr)

Families Citing this family (157)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4812313A (en) * 1981-06-29 1989-03-14 Alza Corporation Method for lessening the incidence of anginal attacks
US4954344A (en) * 1981-06-29 1990-09-04 Alza Corporation Method for treating nocturnal angina
US4849226A (en) * 1981-06-29 1989-07-18 Alza Corporation Method for increasing oxygen supply by administering vasodilator
US4765985A (en) * 1985-03-05 1988-08-23 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4953572A (en) * 1985-04-25 1990-09-04 Rose Jed E Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US5016652A (en) * 1985-04-25 1991-05-21 The Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4920989A (en) * 1985-04-25 1990-05-01 Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4821745A (en) * 1985-11-14 1989-04-18 Rosen David I Apparatus and method for overcoming the habit of tobacco smoking
US5316759A (en) * 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
US5055478A (en) * 1986-06-19 1991-10-08 Cooper Thomas M Method for stopping smoking
US5820876A (en) * 1986-08-28 1998-10-13 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system
US6126963A (en) * 1986-08-28 2000-10-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US6139868A (en) * 1986-08-28 2000-10-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US6110488A (en) * 1986-08-28 2000-08-29 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US6117448A (en) * 1986-08-28 2000-09-12 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
USRE37934E1 (en) 1986-08-28 2002-12-10 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system
US5344656A (en) * 1986-09-12 1994-09-06 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
DE3786998D1 (de) * 1986-11-20 1993-09-16 Ciba Geigy Ag Benutzer-aktivierte therapeutische systeme.
US4911707A (en) * 1987-02-13 1990-03-27 Ciba-Geigy Corporation Monolithic user-activated transdermal therapeutic system
CH674618A5 (fr) 1987-04-02 1990-06-29 Ciba Geigy Ag
IL86170A (en) * 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
DE3743947A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur gesteuerten abgabe von nicotin, verfahren zu ihrer herstellung sowie ihre verwendung
US4839174A (en) * 1987-10-05 1989-06-13 Pharmetrix Corporation Novel transdermal nicotine patch
US4943435A (en) * 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
US4781924A (en) 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US4837027A (en) * 1987-11-09 1989-06-06 Alza Corporation Transdermal drug delivery device
EP0395683A4 (en) * 1987-11-19 1991-01-30 Indaus International Pty Ltd Nicotine compositions
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5004610A (en) * 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5364630A (en) * 1988-06-14 1994-11-15 Alza Corporation Subsaturated nicotine transdermal therapeutic system
DE3844247A1 (de) * 1988-12-29 1990-07-12 Minnesota Mining & Mfg Vorrichtung, insbesondere pflaster zum transdermalen verabreichen eines medikaments
IE62662B1 (en) * 1989-01-06 1995-02-22 Elan Corp Plc Use of nicotine in the treatment of conditions susceptible to said treatment
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
DE3908432A1 (de) * 1989-03-14 1990-09-27 Lohmann Therapie Syst Lts Pflaster als therapeutisches system zur verabreichung von wirkstoffen an die haut mit einer abgestuften wirkstoffabgabe, verfahren zu seiner herstellung sowie verwendung
MX21452A (es) * 1989-07-07 1994-01-31 Ciba Geigy Ag Preparaciones farmaceuticas que se administran en forma topica.
US5139786A (en) * 1989-07-07 1992-08-18 Ciba-Geigy Corporation Topical formulations
US5230896A (en) * 1989-10-12 1993-07-27 Warner-Lambert Company Transdermal nicotine delivery system
US5077104A (en) * 1989-12-21 1991-12-31 Alza Corporation Nicotine packaging materials
US5508038A (en) * 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
US5147654A (en) * 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
US5156847A (en) * 1990-09-20 1992-10-20 Walter H. Lewis Wound-healing composition
US5035252A (en) * 1990-12-14 1991-07-30 Mondre Steven J Nicotine-containing dental floss
US5135753A (en) * 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US5268179A (en) * 1992-02-14 1993-12-07 Ciba-Geigy Corporation Ultrasonically sealed transdermal drug delivery systems
DE4301782C1 (de) * 1993-01-23 1994-08-25 Lohmann Therapie Syst Lts Verwendung von Galanthamin zur Behandlung der Nicotinabhängigkeit
US5503844A (en) * 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
US5962011A (en) * 1993-12-06 1999-10-05 Schering-Plough Healthcare Products, Inc. Device for delivery of dermatological ingredients
US5466465A (en) * 1993-12-30 1995-11-14 Harrogate Holdings, Limited Transdermal drug delivery system
AU676430B2 (en) * 1994-03-07 1997-03-06 Theratech, Inc. Drug-containing adhesive composite transdermal delivery device
US5427099A (en) * 1994-03-17 1995-06-27 Adams; Timothy L. Marker for magnetic resonance imaging
WO1995028144A1 (fr) * 1994-04-13 1995-10-26 Ciba-Geigy Ag Systemes d'administration de medicaments, a liberation controlee dans le temps
US5474782A (en) * 1994-05-20 1995-12-12 Woundfast Pharmaceuticals, Inc. Wound-healing composition and method
AU2703795A (en) * 1994-06-23 1996-01-19 Procter & Gamble Company, The Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
US6166032A (en) * 1997-02-07 2000-12-26 Synapse Pharmaceuticals International, Inc. Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use
US5760049A (en) * 1997-02-21 1998-06-02 Synapse Pharmaceuticals International, Inc. Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use
US6132762A (en) * 1997-05-05 2000-10-17 Cristobal; Walter Transcutaneous application of marijuana
EP0991404A1 (fr) * 1997-06-24 2000-04-12 Schering-Plough Healthcare Products, Inc. Dispositif d'administration d'ingredients dermatologiques
US5932617A (en) * 1998-02-06 1999-08-03 Woundfast Pharmaceuticals Inc. Wound-treating composition and method
AU767586B2 (en) 1998-07-09 2003-11-20 Cephalon, Inc. Methods and compositions for the treatment of chronic lymphocytic leukemia
CN101693023A (zh) 1998-12-18 2010-04-14 阿尔扎有限公司 透明的透皮烟碱输送装置
US6242473B1 (en) 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
US6270781B1 (en) 1999-01-08 2001-08-07 Maxim Pharmaceuticals, Inc. Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
DE19906979B4 (de) 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
US20030102246A1 (en) * 1999-03-20 2003-06-05 Lts Lohmann Therapie-Systeme Ag Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
US6328988B1 (en) * 1999-04-23 2001-12-11 Rutgers, The State University Of New Jersey Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules
US6545034B1 (en) * 1999-07-23 2003-04-08 The Regents Of The University Of California Use of etodolac for the treatment of chronic lymphocytic leukemia
US7151100B1 (en) * 1999-07-23 2006-12-19 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7361680B2 (en) * 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
US7129262B2 (en) * 1999-07-23 2006-10-31 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
AU2001282064B2 (en) * 2000-08-03 2007-02-01 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US20040152672A1 (en) * 2000-08-09 2004-08-05 Carson Dennis A. Indole compounds useful for the treatment of cancer
US6726920B1 (en) * 2000-09-22 2004-04-27 Durect Corporation Implantable drug delivery patch
US6821281B2 (en) 2000-10-16 2004-11-23 The Procter & Gamble Company Microstructures for treating and conditioning skin
US7828827B2 (en) 2002-05-24 2010-11-09 Corium International, Inc. Method of exfoliation of skin using closely-packed microstructures
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
DE10121471A1 (de) * 2001-05-02 2002-11-07 Beiersdorf Ag Oberflächendotierte wirkstoffhaltige Pflaster
MXPA04000354A (es) * 2001-07-12 2004-07-23 Univ Rutgers Macromoleculas similares a estrella anfifilica para suministro de farmaco.
EP1435984A1 (fr) * 2001-10-19 2004-07-14 Maxim Pharmaceuticals, Inc. Utilisation d'histamine pour traiter une maladie du foie
EP1448127A1 (fr) * 2001-11-06 2004-08-25 Maxim Pharmaceuticals, Inc. Compositions pour le traitement de maladies infectieuses
DE10235556A1 (de) * 2002-08-03 2004-02-19 Hf Arzneimittelforschung Gmbh Medikament und Verfahren zur Verringerung des Alkohol- und/oder Tabakkonsums
JP2006501224A (ja) * 2002-08-22 2006-01-12 ニュートリション ２１、インコーポレイテッド アルギニンケイ酸塩イノシトール複合体およびその使用
WO2004026116A2 (fr) * 2002-09-19 2004-04-01 The Regents Of The University Of California Utilisation d'etodoclac aux fins de traitement de l'hyperplasie
EP2422772A3 (fr) 2002-09-20 2012-04-18 Alpharma, Inc. Séquestration de sous-unité et compositions et procédés associés
CA2530996C (fr) * 2003-07-03 2013-05-07 Corium International, Inc. Pansement, dispositif d'administration d'ingredient et dispositif de fixation intraveineux et procede associe
US7387788B1 (en) 2003-10-10 2008-06-17 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof
PT1670433E (pt) 2003-10-10 2012-02-08 Ferring Bv Fórmula farmacológica transdérmica para a minimização de resíduos na pele
US20050171192A1 (en) * 2003-12-11 2005-08-04 Gehlsen Kurt R. Use of histamine to treat bone disease
CA2560840C (fr) 2004-03-24 2014-05-06 Corium International, Inc. Dispositif d'administration transdermique
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US20060002913A1 (en) * 2004-06-22 2006-01-05 Gehlsen Kurt R Use of histamine and related compounds to treat disorders affecting muscle function
WO2006066244A2 (fr) 2004-12-17 2006-06-22 Cash Alan B Procede d'extension de la duree de vie et de retardement de l'apparition de maladies associees au vieillissement
US7309809B2 (en) * 2005-02-26 2007-12-18 Xennovate Medical Llc Adhesive attachment and removal device
WO2006125642A1 (fr) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Procedes et dispositifs d'application transdermique ou transmucosale de testosterone
JP5000932B2 (ja) * 2005-06-21 2012-08-15 日東電工株式会社 ニコチン含有経皮吸収製剤
KR100699582B1 (ko) 2005-07-11 2007-03-23 삼성전기주식회사 출력 버퍼회로
EP2308480B1 (fr) 2005-09-23 2014-08-13 ALZA Corporation Formulation de polyacrylate hautement chargée en activateur pour des applications transdermiques
US20070098772A1 (en) * 2005-09-23 2007-05-03 Westcott Tyler D Transdermal norelgestromin delivery system
ES2499067T3 (es) * 2005-10-13 2014-09-26 Nitto Denko Corporation Preparación transdérmica de nicotina y método de producción de la misma
CA2646667C (fr) 2006-04-21 2014-03-11 Antares Pharma Ipl Ag Methode de traitement des bouffees de chaleur par des preparations transdermiquea ou transmucosiques
HUE032156T2 (en) 2006-06-19 2017-09-28 Alpharma Pharmaceuticals Llc Pharmaceutical preparations
US7569612B1 (en) 2006-08-21 2009-08-04 Mutual Pharmaceutical Company, Inc. Methods of use of fenofibric acid
CA2676221C (fr) 2007-01-22 2016-12-20 Corium International, Inc. Applicateurs pour micro-aiguilles
DE102007006244B4 (de) 2007-02-08 2012-03-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe
WO2008103818A1 (fr) * 2007-02-21 2008-08-28 University Of Louisville Research Foundation Compositions thérapeutiques à base de cotinine
EP2146689B1 (fr) 2007-04-16 2020-08-12 Corium, Inc. Réseaux de micro-aiguilles coulées dans un solvant contenant un actif
US8911749B2 (en) 2007-04-16 2014-12-16 Corium International, Inc. Vaccine delivery via microneedle arrays
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US8991402B2 (en) 2007-12-18 2015-03-31 Pax Labs, Inc. Aerosol devices and methods for inhaling a substance and uses thereof
US10327467B2 (en) 2010-04-14 2019-06-25 Altria Client Services Llc Preformed smokeless tobacco product
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
JP6327852B2 (ja) 2010-05-04 2018-05-23 コリウム インターナショナル， インコーポレイテッド 微小突起アレイを使用した副甲状腺ホルモンの経皮送達のための方法及びデバイス
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
FR2987561B1 (fr) * 2012-03-02 2014-04-11 Pf Medicament Dispositif transdermique comprenant des micro-particules poreuses
CA2896188C (fr) 2012-12-21 2021-02-23 Corium International, Inc. Micro-reseau pour la distribution d'un agent therapeutique et ses procedes d'utilisation
US10245422B2 (en) 2013-03-12 2019-04-02 Corium International, Inc. Microprojection applicators and methods of use
EP2968751B1 (fr) 2013-03-15 2022-11-30 Corium, Inc. Applicateurs de microprojection d'impacts multiples
US10799548B2 (en) 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
AU2014233541B2 (en) 2013-03-15 2018-11-22 Corium Pharma Solutions, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
CA2906541C (fr) 2013-03-15 2022-06-21 Corium International, Inc. Microreseau pour l'administration d'un agent therapeutique et ses procedes d'utilisation
US10384045B2 (en) 2013-03-15 2019-08-20 Corium, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
KR20230013165A (ko) 2013-05-06 2023-01-26 쥴 랩스, 인크. 에어로졸 장치를 위한 니코틴 염 제제 및 그 방법
WO2015066344A1 (fr) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. Agonistes du récepteur 5-ht2c et compositions et procédés d'utilisation
CA2932464C (fr) 2013-12-05 2023-01-03 Pax Labs, Inc. Formulations liquides de nicotine pour dispositifs generateurs d'aerosol et procedes correspondants
EP3136894B1 (fr) * 2014-04-28 2019-07-31 Philip Morris Products S.A. Inhalateur de poudre de nicotine
AU2015254999B2 (en) 2014-04-28 2019-08-01 Philip Morris Products S.A. Flavoured nicotine powder inhaler
US10624843B2 (en) 2014-09-04 2020-04-21 Corium, Inc. Microstructure array, methods of making, and methods of use
WO2016069875A1 (fr) 2014-10-30 2016-05-06 Arena Pharmaceuticals, Inc. Compositions et procédés permettant de renoncer au tabac
GB2535427A (en) 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
GB2532062A (en) 2014-11-07 2016-05-11 Nicoventures Holdings Ltd Container
US11191735B2 (en) 2015-03-13 2021-12-07 Nutrition 21, Llc Arginine silicate for periodontal disease
MX2017013902A (es) 2015-04-27 2018-03-16 Arena Pharm Inc Agonistas del receptor 5-ht2c y composiciones y metodos de uso.
WO2017004067A1 (fr) 2015-06-29 2017-01-05 Corium International, Inc. Micro-réseau pour l'administration d'un agent thérapeutique, procédés d'utilisation, et procédés de fabrication
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
WO2017117575A1 (fr) * 2015-12-30 2017-07-06 Next Generation Labs, LLC Produits de substitution de la nicotine comprenant une nicotine de synthèse
EA038219B1 (ru) 2016-08-19 2021-07-26 Арена Фармасьютикалз, Инк. Агонисты рецептора 5-ht2c и композиции, а также способ их применения
EP3506895A4 (fr) 2016-09-01 2020-04-15 JDS Therapeutics, LLC Compositions de biotinate de magnésium et méthodes d'utilisation
WO2018057737A1 (fr) 2016-09-22 2018-03-29 Cash Alan B Méthode pour soulager les symptômes du spm
WO2018106723A1 (fr) * 2016-12-05 2018-06-14 Chrono Therapeutics Inc. Dispositifs et méthodes d'administration transdermique de médicament
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム
CN112384504A (zh) 2018-06-15 2021-02-19 R.J.雷诺兹烟草公司 烟碱的纯化
KR20210110572A (ko) 2018-11-02 2021-09-08 뉴트리션 21, 엘엘씨 비디오 게이머의 인지 기능 개선을 위한 이노시톨 안정화 아르기닌 실리케이트 복합체 및 이노시톨을 함유하는 조성물
US10661065B1 (en) * 2019-02-07 2020-05-26 Neil Brereton Jackson Systems, devices, and/or methods for managing transdermal patches
EP4076413A1 (fr) 2019-12-16 2022-10-26 Nutrition 21, LLC Procédés de production de complexes d'arginine-silicate
WO2022155349A1 (fr) 2021-01-14 2022-07-21 Cash Alan B Traitement de la fatigue pathologique à l'aide d'oxaloacétate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1775998A (en) * 1929-09-19 1930-09-16 Greenberg Joseph Medicated handkerchief
NL107185C (fr) * 1957-12-19
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3731683A (en) * 1971-06-04 1973-05-08 Alza Corp Bandage for the controlled metering of topical drugs to the skin
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3948254A (en) * 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
CA1163195A (fr) * 1980-06-26 1984-03-06 Alec D. Keith Milieu de diffusion polymerique contenant un vasodilatateur
DE3438284A1 (de) * 1984-10-16 1985-03-07 Hans-Harald von 2400 Lübeck Tilly Nikotinhaltiges depotpflaster

Also Published As

Publication number Publication date
EP0498468A1 (fr) 1992-08-12
EP0246385A1 (fr) 1987-11-25
EP0246385B1 (fr) 1993-04-21
EP0498468B1 (fr) 1996-09-25
HK7794A (en) 1994-02-04
DE3688329T2 (de) 1993-09-23
ATE88366T1 (de) 1993-05-15
US4597961A (en) 1986-07-01
DE3688329D1 (de) 1993-05-27

Similar Documents

Publication Publication Date Title
HK7794A (en) Transcutaneous application of nicotine
GB1315626A (en) Substituted p-menthanes and compositions containing them
EP0316065A3 (en) Improved transdermal drug delivery device
RU94040387A (ru) Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
EP0289342B1 (fr) Méthode de traitement des symptomes de manque associés à la cessation de fumer et des préparations pour l'utilisation dans cette méthode
ES8602774A1 (es) Un procedimiento para producir un preparado farmaceutico percutaneo para uso externo
GB2023995B (en) Process for reduction of nitrate and nicotine content of tobacco by microbial treatment
HUT46710A (en) Process for producing peptode derivatives and pharmaceutical compositions containing them as active components
UA35568C2 (uk) Інгалятор
HUT55643A (en) Process for producing transdermal therapy system containing buprenorfin as agent
EP0321943A3 (fr) Substitut non combustible du tabac
ZA79778B (en) New propanone derivatives,process for producing thereof and pharmaceutical composition containing this derivative as active ingredient
HUT48251A (en) Process for producing new xantin derivatives and pharmaceutical compositions containing them as active components
AU1176688A (en) Method of treatment comprising transcutaneous administration of prostaglandin E1 derivatives
HUT47210A (en) Insecticide compositions and process for producing benzoyl-urea derivatives as active components
ES8800040A1 (es) Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides.
HUT49320A (en) Process for producing ornithine derivatives and pharmaceutical compositions containing them as active components
IL88222A0 (en) Medicaments comprising 2-pyrimidinyl-1-piperazine derivatives
HUT47902A (en) Process for producing anilino-phenyl-thiourea-, -isothiourea- and -carbodiimid derivatives and insecticide compositions containing them as active components
AU2702795A (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration
Magnus Superman and the Marlboro woman: The lungs of Lois Lane.
AU3538489A (en) Homogeneous dimeric m-csf and storage stable formulations thereof
GB2004183A (en) Compositions containing caffeine and ephedrine or their derivatives
GB1242368A (en) Improvements in or relating to a tobacco product
JPS548800A (en) Filter for tobacco smoke